AU2003229263A8 - Specific gene expression in colonic cancer cell lines - Google Patents

Specific gene expression in colonic cancer cell lines

Info

Publication number
AU2003229263A8
AU2003229263A8 AU2003229263A AU2003229263A AU2003229263A8 AU 2003229263 A8 AU2003229263 A8 AU 2003229263A8 AU 2003229263 A AU2003229263 A AU 2003229263A AU 2003229263 A AU2003229263 A AU 2003229263A AU 2003229263 A8 AU2003229263 A8 AU 2003229263A8
Authority
AU
Australia
Prior art keywords
cell lines
gene expression
cancer cell
specific gene
colonic cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229263A
Other versions
AU2003229263A1 (en
Inventor
Andreas Block
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitatsklinikum Hamburg Eppendorf
Original Assignee
Universitatsklinikum Hamburg Eppendorf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatsklinikum Hamburg Eppendorf filed Critical Universitatsklinikum Hamburg Eppendorf
Publication of AU2003229263A8 publication Critical patent/AU2003229263A8/en
Publication of AU2003229263A1 publication Critical patent/AU2003229263A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003229263A 2002-03-05 2003-03-04 Specific gene expression in colonic cancer cell lines Abandoned AU2003229263A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10209451.9 2002-03-05
DE2002109451 DE10209451A1 (en) 2002-03-05 2002-03-05 Specific gene expression in colon carcinoma cell lines
PCT/DE2003/000669 WO2003074692A2 (en) 2002-03-05 2003-03-04 Specific gene expression in colonic cancer cell lines

Publications (2)

Publication Number Publication Date
AU2003229263A8 true AU2003229263A8 (en) 2003-09-16
AU2003229263A1 AU2003229263A1 (en) 2003-09-16

Family

ID=27762662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229263A Abandoned AU2003229263A1 (en) 2002-03-05 2003-03-04 Specific gene expression in colonic cancer cell lines

Country Status (3)

Country Link
AU (1) AU2003229263A1 (en)
DE (1) DE10209451A1 (en)
WO (1) WO2003074692A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816131B2 (en) 2004-04-02 2010-10-19 Board Of Regents, The University Of Texas System Cancer specific promoters
CN108531458A (en) * 2018-04-27 2018-09-14 赛诺（深圳）生物医药研究有限公司 Treat the genetic engineering natural killer cells product of tumour

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082722A1 (en) * 2001-08-08 2003-05-01 Bingliang Fang Method for amplifying expression from a cell specific promoter

Also Published As

Publication number Publication date
AU2003229263A1 (en) 2003-09-16
WO2003074692A3 (en) 2003-12-18
WO2003074692A2 (en) 2003-09-12
DE10209451A1 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
EP1664716A4 (en) Biomarkers in cancer
AU2002211313A1 (en) Gene expression profiles in liver cancer
GB2418259B (en) Improvements in touch technology
PL376971A1 (en) Amplified genes involved in cancer
AU2003220387A8 (en) Gene amplification in cancer
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
EP1651963A4 (en) Monocarboxylate transporters expressed in cancer cells
AU8026300A (en) Sodd gene expression in cancer
AU2003227861A8 (en) Protein involved in cancer
AU2003217222A1 (en) In vivo gene transfer
EP1636384A4 (en) Gene amplification and overexpression in cancer
AU2003229263A8 (en) Specific gene expression in colonic cancer cell lines
AU2003212826A1 (en) Cancer genes
AU2001286809A1 (en) Genes expressed in the cell cycle
GB2419530B (en) Human prostate cell lines in cancer treatment
AU2002364077A8 (en) Gene expression profiles in stomach cancer
GB0407620D0 (en) Cell lines
AU2003269557A1 (en) Gene families associated with cancers
AU2003299491A8 (en) Fagopyritol synthase genes and uses thereof
AU2003300328A8 (en) Fanc gene mutations in cancer
AU2003252034A1 (en) Genes differentially expressed in breast cancer
AU2003239679A1 (en) Improvements in greetins cards
AU2003226557A8 (en) Differentially expressed genes in conjunctivial pterygium
GB2428804B (en) Improvements in touch technology
IL162733A0 (en) Genetic polymorphisms in the preprotachykinin gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase